The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrative analysis of sarcomatoid clear-cell renal cell carcinomas reveals an immune subgroup.
 
Gabriel G. Malouf
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
 
Ronan Flippot
No Relationships to Disclose
 
Roger Mouawad
No Relationships to Disclose
 
Hui Yao
No Relationships to Disclose
 
Eva Comperat
No Relationships to Disclose
 
Morgan Roupret
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; GlaxoSmithKline; Intuitive Surgical; Ipsen; Janssen-Cilag; Lilly; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Coloplast
 
David Khayat
Stock and Other Ownership Interests - Agenus
Consulting or Advisory Role - Atlantic Sante; Celtic Biotech; Fleury Michon; genomic health; Scale Down
 
Jean-Philippe Spano
No Relationships to Disclose
 
Xiaoping Su
No Relationships to Disclose
 
Nizar M. Tannir
Honoraria - Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Epizyme; Exelixis; Mirati Therapeutics; Novartis
Travel, Accommodations, Expenses - Argos Therapeutics; Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer